➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Medtronic
Dow
McKinsey
Baxter

Last Updated: January 17, 2021

DrugPatentWatch Database Preview

Piramal Critical Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for PIRAMAL CRITICAL, and what generic and branded alternatives to PIRAMAL CRITICAL drugs are available?

PIRAMAL CRITICAL has ten approved drugs.



Summary for Piramal Critical
US Patents:0
Tradenames:9
Ingredients:9
NDAs:10

Drugs and US Patents for Piramal Critical

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Piramal Critical SOJOURN sevoflurane LIQUID;INHALATION 077867-001 May 2, 2007 AN RX No No   Start Trial   Start Trial
Piramal Critical GLYCOPYRROLATE glycopyrrolate INJECTABLE;INJECTION 210842-001 Oct 25, 2018 AP RX No No   Start Trial   Start Trial
Piramal Critical ISOFLURANE isoflurane LIQUID;INHALATION 074416-001 Sep 30, 1994 AN RX No No   Start Trial   Start Trial
Piramal Critical ENFLURANE enflurane LIQUID;INHALATION 074396-001 Jul 29, 1994 DISCN No No   Start Trial   Start Trial
Piramal Critical GABLOFEN baclofen INJECTABLE;INTRATHECAL 022462-001 Nov 19, 2010 AP RX No No   Start Trial   Start Trial
Piramal Critical ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 210437-001 Aug 13, 2019 AP RX No No   Start Trial   Start Trial
Piramal Critical GABLOFEN baclofen INJECTABLE;INTRATHECAL 022462-004 Jun 22, 2012 AP RX Yes Yes   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for PIRAMAL CRITICAL drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe for Injection 200 mcg/vial ➤ Subscribe 2015-05-01
➤ Subscribe for Injection 100 mcg/vial and 500 mcg/vial ➤ Subscribe 2015-04-14
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
McKinsey
Boehringer Ingelheim
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.